proxyvotesnow.com

Home › Companies › BIOGEN INC. › 2024-2025

BIOGEN INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and BIOGEN INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 17Reported items
  • 845Asset managers
  • 10,768Fund votes
  • 2025-06-17Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIOGEN INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by BIOGEN INC.

These tallies are BIOGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIOGEN INC. — official shareholder meeting results, meeting held 2025-06-17
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Caroline D. Dorsa 90,200,72325,487,099321,364 --10,206,851 Majority: yes
Elect Director: Maria C. Freire 96,061,53819,660,536287,112 --10,206,851 Majority: yes
Elect Director: William A. Hawkins 96,010,44919,771,738226,999 --10,206,851 Majority: yes
Elect Director: Susan K. Langer 96,160,35919,623,542225,285 --10,206,851 Majority: yes
Elect Director: Jesus B. Mantas 93,427,72022,348,175233,291 --10,206,851 Majority: yes
Elect Director: Lloyd Minor 114,975,935692,399340,852 --10,206,851 Majority: yes
Elect Director: Menelas Pangalos 114,986,403695,239327,544 --10,206,851 Majority: yes
Elect Director: Monish Patolawala 115,162,666520,650325,870 --10,206,851 Majority: yes
Elect Director: Eric K. Rowinsky 91,034,03924,745,219229,928 --10,206,851 Majority: yes
Elect Director: Stephen A. Sherwin 95,785,70619,996,175227,305 --10,206,851 Majority: yes
Elect Director: Christopher A. Viehbacher 114,893,329883,866231,991 --10,206,851 Majority: yes
Proposal 2: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast as follows: 120,065,4335,916,416234,188 ---- Majority: yes
Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows: 78,531,75637,113,368364,062 --10,206,851 Majority: yes

Source: BIOGEN INC., Form 8-K — read the filing on EDGAR.

How asset managers voted at the BIOGEN INC. 2024-2025 meeting

Each item below shows how the 845 asset managers that disclosed a BIOGEN INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIOGEN INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Say on Pay - To hold an advisory vote on executive compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 7 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%AGAINST 32%
FOR: 78,531,756AGAINST: 37,113,368

BIOGEN INC.’s own tally for this item (“Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”): 78,531,756 for, 37,113,368 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 53.9% for, 25% against (79% of the company cast a for/against vote).

The 782 asset managers below cast 75% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 75%AGAINST 25%
FOR: 74.6%AGAINST: 25.2%ABSTAIN: 0.0%NOT VOTED: 0.2%
Largest asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard34,715,43571,108 00For
PRIMECAP MANAGEMENT CO/CA/15,477,9410 00For
BlackRock9,937,3722,244,149 00For
State Street7,183,455119,290 00For
Fidelity5,900,051275,400 00For
T. Rowe Price3,843,0771,690,598 00For
Wellington4,643,9300 00For
GEODE CAPITAL MANAGEMENT, LLC3,843,3400 00For
Invesco3,465,9790 00For
PRIMECAP Odyssey Funds2,064,0990 00For
Charles Schwab02,018,148 00Against
Amundi01,806,751 00Against
Northern Trust01,291,400 00Against
Pacer Funds Trust1,284,9680 00For
Two Sigma01,169,699 00Against
UBS0855,165 00Against
First Trust1,023827,922 00Against
DE Shaw0822,563 00Against
Legal & General Investment Management Ltd15,837794,372 00Against
MELLON INVESTMENTS Corp0785,359 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/0773,775 00Against
Point720741,149 00Against
AQR0731,474 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC0636,488 00Against
Prudential/PGIM554,9435,403 00For

Showing the 25 largest of 782 asset managers. See all 782 in the interactive database.

2. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST 22%
FOR: 90,200,723AGAINST: 25,487,099

BIOGEN INC.’s own tally for this item (“Elect Director: Caroline D. Dorsa”): 90,200,723 for, 25,487,099 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 62% for, 17% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 74% of the shares they voted on this item FOR (45,400,390 for, 16,209,323 against).

FOR 74%AGAINST 26%
FOR: 45,400,390 (73.6%)AGAINST: 16,209,323 (26.3%)ABSTAIN: 36,884 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73112,957,299 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National496,181871 00For
JPMorgan0374,925 00Against
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust116,959100,459 00For
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

3. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 114,893,329AGAINST: 883,866

BIOGEN INC.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 114,893,329 for, 883,866 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 79% for, 0.7% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 99.9% of the shares they voted on this item FOR (61,604,492 for, 5,224 against).

FOR 99.9%
FOR: 61,604,492 (99.9%)AGAINST: 5,224 (0.0%)ABSTAIN: 36,881 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,39328 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

4. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%AGAINST 21%
FOR: 91,034,039AGAINST: 24,745,219

BIOGEN INC.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 91,034,039 for, 24,745,219 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 62% for, 17% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 74% of the shares they voted on this item FOR (45,856,633 for, 15,753,083 against).

FOR 74%AGAINST 26%
FOR: 45,856,633 (74.4%)AGAINST: 15,753,083 (25.5%)ABSTAIN: 36,881 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,892,70612,959,324 00For
BlackRock5,398,075941 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust116,959100,459 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X119,1427,633 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

5. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%
FOR: 93,427,720AGAINST: 22,348,175

BIOGEN INC.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 93,427,720 for, 22,348,175 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 64% for, 15% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 74% of the shares they voted on this item FOR (45,892,284 for, 15,714,481 against).

FOR 74%AGAINST 25%
FOR: 45,892,284 (74.4%)AGAINST: 15,714,481 (25.5%)ABSTAIN: 39,833 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust138,69778,721 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

6. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 114,975,935AGAINST: 692,399

BIOGEN INC.’s own tally for this item (“Elect Director: Lloyd Minor”): 114,975,935 for, 692,399 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 79% for, 0.5% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 99.9% of the shares they voted on this item FOR (61,604,523 for, 5,189 against).

FOR 99.9%
FOR: 61,604,523 (99.9%)AGAINST: 5,189 (0.0%)ABSTAIN: 36,885 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

7. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 96,061,538AGAINST: 19,660,536

BIOGEN INC.’s own tally for this item (“Elect Director: Maria C. Freire”): 96,061,538 for, 19,660,536 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 66% for, 13% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 76% of the shares they voted on this item FOR (46,553,935 for, 15,055,779 against).

FOR 76%AGAINST 24%
FOR: 46,553,935 (75.5%)AGAINST: 15,055,779 (24.4%)ABSTAIN: 36,883 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust195,68021,738 00For
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

8. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 114,986,403AGAINST: 695,239

BIOGEN INC.’s own tally for this item (“Elect Director: Menelas Pangalos”): 114,986,403 for, 695,239 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 79% for, 0.5% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 99.9% of the shares they voted on this item FOR (61,604,523 for, 5,190 against).

FOR 99.9%
FOR: 61,604,523 (99.9%)AGAINST: 5,190 (0.0%)ABSTAIN: 36,884 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

9. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 115,162,666AGAINST: 520,650

BIOGEN INC.’s own tally for this item (“Elect Director: Monish Patolawala”): 115,162,666 for, 520,650 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 79% for, 0.4% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 99.9% of the shares they voted on this item FOR (61,604,529 for, 5,183 against).

FOR 99.9%
FOR: 61,604,529 (99.9%)AGAINST: 5,183 (0.0%)ABSTAIN: 36,884 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

10. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 95,785,706AGAINST: 19,996,175

BIOGEN INC.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 95,785,706 for, 19,996,175 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 66% for, 14% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 76% of the shares they voted on this item FOR (46,555,131 for, 15,054,585 against).

FOR 76%AGAINST 24%
FOR: 46,555,131 (75.5%)AGAINST: 15,054,585 (24.4%)ABSTAIN: 36,881 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust195,68021,738 00For
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

11. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 96,160,359AGAINST: 19,623,542

BIOGEN INC.’s own tally for this item (“Elect Director: Susan K. Langer”): 96,160,359 for, 19,623,542 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 66% for, 13% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 74% of the shares they voted on this item FOR (45,524,597 for, 16,085,119 against).

FOR 74%AGAINST 26%
FOR: 45,524,597 (73.8%)AGAINST: 16,085,119 (26.1%)ABSTAIN: 36,881 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National496,181871 00For
JPMorgan0374,925 00Against
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust138,69778,721 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

12. Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 96,010,449AGAINST: 19,771,738

BIOGEN INC.’s own tally for this item (“Elect Director: William A. Hawkins”): 96,010,449 for, 19,771,738 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 66% for, 14% against (79% of the company cast a for/against vote).

The 149 asset managers below cast 76% of the shares they voted on this item FOR (46,543,451 for, 15,066,265 against).

FOR 75%AGAINST 24%
FOR: 46,543,451 (75.5%)AGAINST: 15,066,265 (24.4%)ABSTAIN: 36,881 (0.1%)TNA: 12,400 (0.0%)
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,892,70712,959,323 00For
BlackRock5,398,075941 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust195,68021,738 00For
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X119,1427,633 00For

Showing the 25 largest of 149 asset managers. See all 149 in the interactive database.

13. To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 120,065,433AGAINST: 5,916,416

BIOGEN INC.’s own tally for this item (“Proposal 2: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast as follows:”): 120,065,433 for, 5,916,416 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 82% for, 4% against (86% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (61,523,878 for, 48,035 against).

FOR 99.8%
FOR: 61,523,878 (99.9%)AGAINST: 48,035 (0.1%)ABSTAIN: 36,880 (0.1%)
Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,850,0032,027 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

14. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-17.

68% Majority: yes · of votes cast

FOR 68%AGAINST 32%
FOR: 78,531,756AGAINST: 37,113,368

BIOGEN INC.’s own tally for this item (“Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”): 78,531,756 for, 37,113,368 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 53.9% for, 25% against (79% of the company cast a for/against vote).

The 34 asset managers below cast 44% of the shares they voted on this item FOR (644,035 for, 820,096 against).

FOR 44%AGAINST 56%
FOR: 644,035 (43.6%)AGAINST: 820,096 (55.5%)TNA: 12,400 (0.8%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan595,3090 00For
APG Asset Management US Inc.0351,784 00Against
NORDEA INVESTMENT MANAGEMENT AB089,752 00Against
TD ASSET MANAGEMENT INC065,076 00Against
ADAGE CAPITAL PARTNERS GP, L.L.C.063,179 00Against
GuideStone059,481 00Against
OSSIAM050,658 00Against
Erste Asset Management GmbH42,3390 00For
Cardano Risk Management B.V.037,636 00Against
Union Investment Privatfonds GmbH021,900 00Against
Empower019,827 00Against
Desjardins Global Asset Management Inc.016,601 00Against
iA Global Asset Management Inc.016,112 00Against
AMERICAN BEACON FUNDS00 00Tna
GROUPAMA ASSET MANAGMENT010,231 00Against
Vinva Investment Management Ltd06,601 00Against
Union Investment Institutional GmbH03,694 00Against
TD Waterhouse Canada Inc.02,983 00Against
Metzler Asset Management GmbH2,9370 00For
FAYEZ SAROFIM & CO2,3000 00For
CLEARWATER INVESTMENT TRUST02,100 00Against
Regime de rentes du Mouvement Desjardins01,916 00Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma4450 00For
Convergence Investment Partners, LLC4440 00For
Bellevue Group AG0402 00Against

Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.

15. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 6 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%AGAINST 32%
FOR: 78,531,756AGAINST: 37,113,368

BIOGEN INC.’s own tally for this item (“Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”): 78,531,756 for, 37,113,368 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 53.9% for, 25% against (79% of the company cast a for/against vote).

The 14 asset managers below cast 86% of the shares they voted on this item FOR (17,059 for, 2,695 against).

FOR 86%14%
FOR: 17,059 (86.4%)AGAINST: 2,695 (13.6%)
Largest asset managers voting on “14A Executive Compensation” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
THOR INVESTMENT MANAGEMENT INC /OH/ /ADV10,8780 00For
EAGLE GLOBAL ADVISORS LLC02,625 00Against
Kennondale Capital Management LLC2,6060 00For
Focus Partners Wealth2,0590 00For
Baker Avenue Asset Management, LP7000 00For
Parisi Gray Wealth Management3190 00For
Steele Capital Management, Inc.2200 00For
Empower1640 00For
AMJ Financial Wealth Management070 00Against
Simplify Exchange Traded Funds580 00For
Roble, Belko & Company, Inc250 00For
Claret Asset Management Corp200 00For
BOURNE LENT ASSET MANAGEMENT INC100 00For
Ikarian Capital, LLC00 00--

16. Say on Pay - To hold an advisory vote on executive compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-20 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 114,367,799AGAINST: 5,054,473

BIOGEN INC.’s own tally for this item (“Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”): 114,367,799 for, 5,054,473 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 78% for, 3% against (82% of the company cast a for/against vote).

The 5 asset managers below cast 100% of the shares they voted on this item FOR (1,404 for, 0 against).

FOR 100%
FOR: 1,404 (100.0%)
Largest asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC1,2360 00For
Americana Partners, LLC780 00For
Ipswich Investment Management Co., Inc.700 00For
VAUGHAN DAVID INVESTMENTS LLC/IL200 00For
Echo45 Advisors LLC00 00--

17. Ratify Appointment of Independent Auditors

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 120,065,433AGAINST: 5,916,416

BIOGEN INC.’s own tally for this item (“Proposal 2: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast as follows:”): 120,065,433 for, 5,916,416 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,800,000 outstanding shares: 82% for, 4% against (86% of the company cast a for/against vote).

The 4 asset managers below cast 0.6% of the shares they voted on this item FOR (226 for, 37,636 against).

AGAINST 75%TNA 25%
FOR: 226 (0.4%)AGAINST: 37,636 (74.9%)TNA: 12,400 (24.7%)
Largest asset managers voting on “Ratify Appointment of Independent Auditors” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.037,636 00Against
AMERICAN BEACON FUNDS00 00Tna
MARCO INVESTMENT MANAGEMENT LLC1680 00For
Simplify Exchange Traded Funds580 00For

Largest BIOGEN INC. shareholders voting in 2024-2025

Ranked by the number of BIOGEN INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 145,800,000 shares outstanding at the time of that meeting.

Top BIOGEN INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 23.86%
2PRIMECAP MANAGEMENT CO/CA/ 10.62%
3BlackRock 8.35%
4State Street 5.01%
5Fidelity 4.24%
6T. Rowe Price 3.80%
7Wellington 3.19%
8GEODE CAPITAL MANAGEMENT, LLC 2.64%
9Invesco 2.38%
10PRIMECAP Odyssey Funds 1.42%

Reported BIOGEN INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BIOGEN INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
FMR LLC 11.42% 13G
BlackRock 10.43% 13F
PRIMECAP MANAGEMENT CO/CA/ 10.26% 13G
State Street 5.07% 13F
Wellington Management 3.20% 13F
Invesco 1.55% 13F
Morgan Stanley 1.37% 13F
Citadel Advisors 1.20% 13F
D.E. Shaw 1.18% 13F
Norges Bank 1.04% 13F

Percentages above are of 145,800,000 shares outstanding, as reported by BIOGEN INC. on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOGEN INC.’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At BIOGEN INC.'s shareholder meeting held 2025-06-17, in the 2024-2025 proxy season, 845 asset managers reported how they voted in their SEC Form N-PX filings, covering 10,768 separate fund positions. Their filings are grouped here into 17 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — FOR was 68% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BIOGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

BIOGEN INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.